Swedish Orphan Biovitrum ... (BIOVF)

PNK: BIOVF · Real-Time Price · USD

30.50

-0.16 (-0.51%)

At close: May 02, 2025, 11:30 AM

Swedish Orphan Biovitrum AB (publ) Balance Sheet Statement

Financials in SEK. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	997M	1.14B	594M	779M	527M	904M	678M	790M	198M	1.36B	288M	360M	1.06B	1.04B	212M	233M	633M	404M	164M	213M	842M	737M	1.08B	1.19B	463M	3B	2.49B	2.31B	1.75B	1.48B	1.76B	1.19B	1.03B	785.79M	824M	770M	1.11B
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9M	n/a	n/a	n/a	-9M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	440K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	183M	194M	142M	158M	128M	135M	121M	158M	132M	121M	199M	189M	184M	188M	179M	170M	584M	419M	50M	444M	447M	242M	55M	227M	193M	n/a	35.16M	n/a	n/a	n/a	1.96M	n/a	n/a	n/a
Other Long-Term Assets	412M	434M	377M	32M	n/a	n/a	n/a	1M	n/a	n/a	n/a	1M	-1M	1M	n/a	n/a	n/a	-1M	n/a	585M	420M	-2M	444M	447M	242M	440K	227M	192M	200M	n/a	155M	144M	155M	n/a	147M	80M	92M
Receivables	6.83B	7.86B	n/a	4.81B	5.58B	7.06B	4.23B	4.42B	4.22B	6.14B	3.25B	3.13B	3.75B	4.31B	3.08B	2.34B	3.34B	4.71B	2.14B	2.12B	4.08B	4.81B	1.98B	2.27B	2.36B	2.03B	1.51B	1.55B	1.44B	1.46B	941M	1.03B	888M	1.05B	628M	558M	505M
Inventory	3.88B	4.16B	3.99B	3.73B	3.56B	3.87B	3.93B	4.07B	3.66B	3.33B	3.31B	3.42B	3.37B	3.42B	3.21B	3.3B	3.08B	3.05B	2.54B	2.15B	1.75B	1.77B	1.62B	1.48B	1.45B	1.28B	1.17B	1.19B	1.06B	1.05B	1.09B	1.12B	988M	870.05M	798M	751M	810M
Other Current Assets	n/a	1M	8.06B	2.22B	2.44B	7.06B	2.19B	1.54B	2.22B	6.14B	1.25B	1.13B	1.19B	4.11B	880M	817M	924M	4.53B	620M	624M	806M	4.62B	783M	686M	1.08B	2.17B	489M	512M	457M	1.52B	469M	430M	396M	1.13B	397M	347M	261M
Total Current Assets	11.71B	13.16B	12.65B	11.55B	12.11B	12.67B	11.03B	10.82B	10.3B	11.21B	8.1B	8.04B	9.36B	8.78B	7.39B	6.69B	7.97B	8.17B	5.46B	5.1B	7.48B	7.32B	5.47B	5.62B	5.35B	6.6B	5.66B	5.56B	4.71B	4.16B	4.26B	3.77B	3.3B	2.91B	2.65B	2.43B	2.68B
Property-Plant & Equipment	1.58B	1.58B	384M	253M	257M	251M	264M	307M	270M	274M	309M	360M	380M	493M	481M	491M	516M	535M	564M	594M	514M	519M	508M	488M	539M	136.3M	135M	135M	133M	134.18M	122M	126M	126M	121.02M	107M	111M	101M
Goodwill & Intangibles	55.36B	58.97B	57.88B	60.23B	61.13B	60.12B	63.32B	63.67B	42.34B	40.01B	41.49B	39.11B	38.26B	38.42B	38.18B	38.28B	38.98B	38.79B	37.24B	36.36B	38.02B	37.41B	26.38B	23.61B	23.84B	10.16B	10.24B	6.24B	6.34B	6.45B	6.54B	6.64B	6.75B	6.81B	6.89B	6.97B	5.66B
Total Long-Term Assets	58.41B	62.28B	59.55B	61.62B	62.41B	61.36B	64.55B	64.97B	43.61B	41.28B	42.83B	40.38B	39.45B	39.88B	39.34B	39.51B	40.22B	40.12B	38.67B	37.54B	38.95B	38.34B	27.33B	24.55B	24.62B	10.58B	10.6B	6.57B	6.68B	6.75B	6.81B	6.91B	7.03B	7.06B	7.15B	7.17B	5.85B
Total Assets	70.12B	75.44B	72.19B	73.17B	74.52B	74.03B	75.57B	75.78B	53.91B	52.5B	50.93B	48.43B	48.81B	48.66B	46.73B	46.2B	48.19B	48.28B	44.13B	42.64B	46.43B	45.66B	32.79B	30.17B	29.97B	17.18B	16.27B	12.12B	11.39B	10.9B	11.07B	10.68B	10.33B	9.97B	9.79B	9.59B	8.54B
Account Payables	1.07B	944M	1.37B	1.05B	671M	1.02B	1.05B	933M	625M	1.25B	361M	519M	545M	558M	795M	434M	392M	569M	414M	456M	487M	681M	347M	419M	743M	487M	n/a	n/a	n/a	358.45M	n/a	n/a	n/a	280.17M	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	2.9B	n/a	n/a	n/a	3.13B	n/a	n/a	n/a	5.28B	n/a	n/a	n/a	5.04B	n/a	n/a	n/a	3.4B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.34B	n/a	n/a	n/a	825.1M	n/a	n/a	n/a
Short-Term Debt	3.91B	3.93B	6B	5.94B	7.5B	8.81B	3.25B	10.54B	5.93B	5.8B	1.69B	1.32B	1.02B	1.77B	2.04B	2.02B	4.09B	4.01B	2.11B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	579.89M	2M	2M	2M	496.7M	2M	2M	1M
Other Current Liabilities	6.88B	7.6B	6.39B	8.77B	8.79B	8.81B	9.23B	6.76B	8.02B	7.29B	6.99B	5.91B	7.36B	6.02B	4.96B	5.38B	5.73B	4.91B	4.37B	4.72B	5.17B	4.29B	3.72B	7.01B	6.78B	2.28B	6.55B	2.78B	2.49B	509.56M	2.34B	2.19B	2.02B	952.97M	1.49B	1.38B	1.26B
Total Current Liabilities	11.96B	12.6B	13.9B	15.89B	17.11B	19.09B	13.67B	18.39B	14.71B	14.86B	9.17B	7.88B	9.06B	8.76B	7.91B	7.95B	10.33B	10.44B	7B	5.28B	5.76B	5.74B	4.16B	7.52B	7.6B	6.95B	6.55B	2.78B	2.49B	2.36B	2.34B	2.19B	2.02B	1.76B	1.49B	1.38B	1.26B
Long-Term Debt	9.75B	12.41B	11.47B	10.86B	11.4B	11.36B	17.51B	17.28B	2.97B	2.97B	8.13B	8.12B	8.36B	8.78B	9.3B	9.41B	9.21B	10.14B	10.76B	12.02B	15.04B	16.14B	8.68B	5.59B	6.01B	n/a	4M	5M	5M	1.07B	503M	502M	502M	502.22M	502M	502M	802M
Other Long-Term Liabilities	2.78B	3.17B	2.94B	9.9B	9.94B	9.54B	9.79B	11.53B	8.2B	7.94B	8.34B	7.82B	7.37B	7.44B	7.52B	7.39B	7.5B	6.94B	7.25B	6.36B	6.67B	6.35B	3.97B	1.79B	1.56B	1.19B	1.21B	1.49B	1.68B	765.69M	1.88B	2.02B	2.22B	2.36B	2.43B	2.46B	1.46B
Total Long-Term Liabilities	19.12B	22.55B	21.18B	20.93B	21.51B	21.07B	27.47B	29.02B	11.37B	11.11B	16.7B	16.22B	16B	16.7B	17.08B	17.07B	17B	17.63B	18.35B	18.74B	22.01B	22.99B	12.95B	7.68B	7.89B	1.19B	1.22B	1.49B	1.68B	1.84B	2.38B	2.52B	2.72B	2.86B	2.93B	2.96B	2.26B
Total Liabilities	31.08B	35.15B	35.09B	36.82B	38.62B	40.16B	41.14B	47.41B	26.08B	25.97B	25.87B	24.1B	25.05B	25.46B	24.99B	25.02B	27.33B	28.08B	25.35B	24.02B	27.78B	28.73B	17.11B	15.2B	15.49B	8.14B	7.77B	4.27B	4.17B	4.2B	4.72B	4.71B	4.74B	4.62B	4.42B	4.34B	3.52B
Total Debt	14.02B	16.73B	17.87B	17.1B	19.22B	20.48B	21.07B	28.18B	9.23B	9.1B	10.18B	9.85B	9.77B	10.91B	11.72B	11.82B	13.71B	14.57B	13.31B	12.49B	15.45B	16.56B	9.07B	5.97B	6.41B	2.99M	4M	5M	5M	1.65B	505M	504M	504M	2.81B	504M	504M	803M
Common Stock	195M	195M	195M	194M	194M	194M	194M	171M	170M	170M	25.07B	24.33B	23.76B	169M	21.74B	21.17B	20.86B	167M	18.78B	18.62B	18.65B	165M	15.69B	14.97B	14.48B	149.97M	8.5B	7.85B	7.21B	149.53M	6.35B	5.97B	5.59B	149.25M	5.37B	5.25B	5.02B
Retained Earnings	22.8B	21.92B	20.53B	19.06B	18.84B	18.05B	17.34B	17.25B	17.03B	15.79B	n/a	n/a	n/a	13.15B	n/a	n/a	n/a	10.48B	n/a	n/a	n/a	7.27B	n/a	n/a	n/a	3.97B	n/a	n/a	n/a	1.55B	n/a	n/a	n/a	388.8M	n/a	n/a	n/a
Comprehensive Income	n/a	n/a	n/a	172M	263M	-934M	796M	866M	434M	351M	n/a	n/a	n/a	-66M	n/a	n/a	n/a	-254M	n/a	n/a	n/a	-201M	n/a	n/a	n/a	-144M	n/a	n/a	n/a	-20.39M	n/a	n/a	n/a	4.82B	n/a	n/a	n/a
Shareholders Equity	39.03B	40.29B	37.09B	36.34B	35.89B	33.87B	34.43B	28.38B	27.83B	26.52B	25.07B	24.33B	23.76B	23.2B	21.74B	21.17B	20.86B	20.21B	18.78B	18.62B	18.65B	16.93B	15.69B	14.97B	14.48B	9.04B	8.5B	7.85B	7.21B	6.7B	6.35B	5.97B	5.59B	5.35B	5.37B	5.25B	5.02B
Total Investments	176M	166M	175M	183M	194M	142M	158M	128M	135M	112M	158M	132M	121M	190M	189M	184M	188M	179M	170M	584M	419M	50M	444M	447M	242M	55.44M	227M	193M	n/a	35.16M	n/a	n/a	n/a	1.96M	n/a	n/a	n/a